Natera Revenue 2014-2023 | NTRA
- Natera revenue for the quarter ending December 31, 2023 was $0.311B, a 43.2% increase year-over-year.
- Natera revenue for the twelve months ending December 31, 2023 was $1.083B, a 31.99% increase year-over-year.
- Natera annual revenue for 2023 was $1.083B, a 31.99% increase from 2022.
- Natera annual revenue for 2022 was $0.82B, a 31.13% increase from 2021.
- Natera annual revenue for 2021 was $0.625B, a 59.97% increase from 2020.
Natera Annual Revenue (Millions of US $) |
|
---|---|
2023 | $1,083 |
2022 | $820 |
2021 | $625 |
2020 | $391 |
2019 | $302 |
2018 | $258 |
2017 | $210 |
2016 | $213 |
2015 | $190 |
2014 | $159 |
2013 | $55 |
Natera Quarterly Revenue (Millions of US $) |
|
---|---|
2023-12-31 | $311 |
2023-09-30 | $268 |
2023-06-30 | $261 |
2023-03-31 | $242 |
2022-12-31 | $217 |
2022-09-30 | $211 |
2022-06-30 | $198 |
2022-03-31 | $194 |
2021-12-31 | $173 |
2021-09-30 | $158 |
2021-06-30 | $142 |
2021-03-31 | $152 |
2020-12-31 | $112 |
2020-09-30 | $98 |
2020-06-30 | $86 |
2020-03-31 | $94 |
2019-12-31 | $83 |
2019-09-30 | $78 |
2019-06-30 | $74 |
2019-03-31 | $67 |
2018-12-31 | $67 |
2018-09-30 | $65 |
2018-06-30 | $63 |
2018-03-31 | $62 |
2017-12-31 | $52 |
2017-09-30 | $56 |
2017-06-30 | $52 |
2017-03-31 | $49 |
2016-12-31 | $45 |
2016-09-30 | $54 |
2016-06-30 | $52 |
2016-03-31 | $62 |
2015-12-31 | $53 |
2015-09-30 | $45 |
2015-06-30 | $45 |
2015-03-31 | $47 |
2014-12-31 | |
2014-09-30 | $46 |
2014-06-30 | $36 |
2013-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $10.868B | $1.083B |
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $120.362B | 15.62 |
Cencora (COR) | United States | $48.434B | 19.33 |
ICON (ICLR) | Ireland | $27.216B | 26.84 |
DiDi Global (DIDIY) | China | $18.072B | 0.00 |
Avantor (AVTR) | United States | $17.215B | 23.72 |
CochLear (CHEOY) | $14.342B | 0.00 | |
Viatris (VTRS) | United States | $13.916B | 3.97 |
Charles River Laboratories (CRL) | United States | $13.617B | 24.92 |
Revvity (RVTY) | United States | $12.775B | 22.24 |
Medpace Holdings (MEDP) | United States | $12.388B | 45.35 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.873B | 0.00 |
HealthEquity (HQY) | United States | $6.819B | 50.95 |
Amplifon S.p.A (AMFPF) | Italy | $6.762B | 34.33 |
Bausch + Lomb (BLCO) | Canada | $5.939B | 22.86 |
Doximity (DOCS) | United States | $5.035B | 37.49 |
Organon (OGN) | United States | $4.632B | 4.49 |
Surgery Partners (SGRY) | United States | $3.696B | 34.34 |
Progyny (PGNY) | United States | $3.574B | 59.74 |
Sotera Health (SHC) | United States | $3.261B | 16.01 |
Life Times (LTH) | United States | $2.896B | 32.00 |
GoodRx Holdings (GDRX) | United States | $2.789B | 141.20 |
Premier (PINC) | United States | $2.587B | 9.47 |
Teladoc Health (TDOC) | United States | $2.514B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.341B | 7.57 |
Agilon Health (AGL) | United States | $2.044B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.688B | 0.00 |
NovoCure (NVCR) | Jersey | $1.400B | 0.00 |
Agiliti (AGTI) | United States | $1.383B | 22.60 |
Establishment Labs Holdings (ESTA) | $1.352B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $0.888B | 0.00 |
Pediatrix Medical (MD) | United States | $0.807B | 8.34 |
Embecta (EMBC) | United States | $0.711B | 4.70 |
COMPASS Pathways (CMPS) | United Kingdom | $0.577B | 0.00 |
InnovAge Holding (INNV) | United States | $0.576B | 0.00 |
Enhabit (EHAB) | United States | $0.569B | 51.54 |
Beauty Health (SKIN) | United States | $0.537B | 0.00 |
CareDx (CDNA) | United States | $0.496B | 0.00 |
MultiPlan (MPLN) | United States | $0.487B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.466B | 12.21 |
LifeMD (LFMD) | United States | $0.446B | 0.00 |
DocGo (DCGO) | United States | $0.405B | 64.83 |
ModivCare (MODV) | United States | $0.340B | 4.51 |
Sharecare (SHCR) | United States | $0.305B | 0.00 |
Sera Prognostics (SERA) | United States | $0.298B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.271B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.264B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.228B | 0.00 |
Biodesix (BDSX) | United States | $0.141B | 0.00 |
Oncology Institute (TOI) | United States | $0.125B | 0.00 |
So-Young (SY) | China | $0.107B | 35.67 |
Pono Capital Two (PTWO) | United States | $0.070B | 0.00 |
Nutex Health (NUTX) | United States | $0.069B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.050B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.041B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.038B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
OncoCyte (OCX) | United States | $0.025B | 0.00 |
BIMI Medical (BIMI) | United States | $0.023B | 0.00 |
DermTech (DMTK) | United States | $0.023B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.011B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.011B | 0.00 |
OpGen (OPGN) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |